Status:

COMPLETED

Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses

Lead Sponsor:

Yuzuncu Yil University

Conditions:

Nesfatin-1

Irisin

Eligibility:

FEMALE

18-45 years

Brief Summary

: The aim of this study is to investigate Cord blood irisin and nesfatin-1 levels in pregnancies with intrauterine growth retardation and to determine whether they are associated with abnormal fetal d...

Detailed Description

This study was conducted at Yüzüncü Yıl University Medical Faculty Obstetrics and Gynecology Clinic. The study group included 34 pregnant women ranged from 18 to 45 years old who have intrauterine gro...

Eligibility Criteria

Inclusion

  • Pregnant women with intrauterine grwoth rectricted fetuses.
  • Healthy pregnancies

Exclusion

  • Pregnant women with chronic medical conditions
  • multiple pregnancies
  • fetuses with fetal malfomations or genetic syndromes
  • pregnant women older than 45 years old

Key Trial Info

Start Date :

January 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 15 2019

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT03808571

Start Date

January 1 2018

End Date

January 15 2019

Last Update

January 22 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yuzuncu Yil University, Medical faculty, department of obstetric and gynecology

Van, Turkey (Türkiye), 65000